Compounds > cefodizime
Page last updated: 2024-08-23

cefodizime and dibekacin

cefodizime has been researched along with dibekacin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Suzuki, Y; Yokota, N1
Deguchi, K; Furukawa, T; Hyodo, A; Miyake, Y; Uji, T1

Other Studies

3 other study(ies) available for cefodizime and dibekacin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
[Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. IV. Synergistic action with dibekacin].
    The Japanese journal of antibiotics, 1992, Volume: 45, Issue:5

    Topics: Bacteria; Cefotaxime; Dibekacin; Drug Resistance, Microbial; Drug Synergism

1992
[Therapeutic efficacy of cefodizime in combination with aminoglycosides against systemic infections caused by Pseudomonas aeruginosa in immunocompromised tumour bearing mice].
    The Japanese journal of antibiotics, 1993, Volume: 46, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Immunocompromised Host; Male; Mice; Mice, Inbred Strains; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Sisomicin

1993